Skip to main content
. 2012 May 16;7(5):e36833. doi: 10.1371/journal.pone.0036833

Figure 3. Inhibition of Nipah virus envelope glycoproteins mediated fusion by the HPIV-3 HRC-derived fusion inhibitors HPIV-P2 (○), the monomeric cholesterol-tagged fusion inhibitor HPIV-P3 (•), the dimeric fusion inhibitor HPIV-P5 (□), and the dimeric cholesterol-tagged inhibitor HPIV-P4 (▪).

Figure 3

The percent inhibition of fusion (compared to control cells not treated with peptide) is shown as a function of the (log-scale) concentration of peptide. The values are means (±SD) of the results from three experiments.